메뉴 건너뛰기




Volumn 31, Issue 9, 2010, Pages 950-960

Clinical trial: Maintenance intermittent therapy with rabeprazole 20 mg in patients with symptomatic gastro-oesophageal reflux disease - A double-blind, placebo-controlled, randomized study

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RABEPRAZOLE; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ANTIULCER AGENT;

EID: 77950575679     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04254.x     Document Type: Article
Times cited : (10)

References (23)
  • 1
    • 0037345718 scopus 로고    scopus 로고
    • Towards a consensus in symptomatic gastroesophageal reflux disease: Introduction
    • DOI 10.1016/S0002-9270(03)00008-X
    • Fass R. Epidemiology and pathophysiology of symptomatic gastroesophageal reflux disease. Am J Gastroenterol 2003 98 : S2 7. (Pubitemid 36348508)
    • (2003) American Journal of Gastroenterology , vol.98 , Issue.3 SUPPL.
    • Fass, R.1
  • 2
    • 0037345566 scopus 로고    scopus 로고
    • Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease patients
    • Bytzer P. Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease patients. Am J Gastroenterol 2003 98 : S31 9.
    • (2003) Am J Gastroenterol , vol.98 , pp. 31-9
    • Bytzer, P.1
  • 3
    • 33750136298 scopus 로고    scopus 로고
    • Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease
    • van Pinxteren B, Numans ME, Bonis PA, Lau J. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev 2006 3 : CD002095.
    • (2006) Cochrane Database Syst Rev , vol.3
    • Van Pinxteren, B.1    Numans, M.E.2    Bonis, P.A.3    Lau, J.4
  • 4
    • 0036677469 scopus 로고    scopus 로고
    • Gastroesophageal reflux disease - Should we adopt a new conceptual framework?
    • Fass R, Ofman JJ. Gastroesophageal reflux disease - should we adopt a new conceptual framework? Am J Gastroenterol 2002 97 : 1901 1909.
    • (2002) Am J Gastroenterol , vol.97 , pp. 1901-1909
    • Fass, R.1    Ofman, J.J.2
  • 7
    • 27144502406 scopus 로고    scopus 로고
    • Efficacy of rabeprazole in the treatment of symptomatic gastroesophageal reflux disease
    • DOI 10.1007/s10620-005-3000-3
    • Kahrilas PJ, Miner P, Johanson J, Mao L, Jokubaitis L, Sloan S. Efficacy of rabeprazole in the treatment of symptomatic gastroesophageal reflux disease. Dig Dis Sci 2005 50 : 2009 2018. (Pubitemid 41504082)
    • (2005) Digestive Diseases and Sciences , vol.50 , Issue.11 , pp. 2009-2018
    • Kahrilas, P.J.1    Miner, P.2    Johanson, J.3    Mao, L.4    Jokubaitis, L.5    Sloan, S.6
  • 8
    • 0037343926 scopus 로고    scopus 로고
    • Diagnosis of symptomatic gastroesophageal reflux disease
    • Kahrilas PJ. Diagnosis of symptomatic gastroesophageal reflux disease. Am J Gastroenterol 2003 98 : S15 23.
    • (2003) Am J Gastroenterol , vol.98 , pp. 15-23
    • Kahrilas, P.J.1
  • 10
    • 0033011401 scopus 로고    scopus 로고
    • Factors influencing compliance in long-term proton pump inhibitor therapy in general practice
    • Hungin AP, Rubin G, O'Flanagan H. Factors influencing compliance in long-term proton pump inhibitor therapy in general practice. Br J Gen Pract 1999 49 : 463 464. (Pubitemid 29304147)
    • (1999) British Journal of General Practice , vol.49 , Issue.443 , pp. 463-464
    • Hungin, A.P.S.1    Rubin, G.2    O'Flanagan, H.3
  • 11
    • 20444455328 scopus 로고    scopus 로고
    • 2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients
    • DOI 10.1111/j.1365-2036.2005.02490.x
    • Zacny J, Zamakhshary M, Sketris I, Veldhuyzen van Zanten S. Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients. Aliment Pharmacol Ther 2005 21 : 1299 1312. (Pubitemid 40813676)
    • (2005) Alimentary Pharmacology and Therapeutics , vol.21 , Issue.11 , pp. 1299-1312
    • Zacny, J.1    Zamakhshary, M.2    Sketris, I.3    Van Zanten, S.V.4
  • 14
    • 0036667969 scopus 로고    scopus 로고
    • Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: A placebo-controlled trial of on-demand therapy for 6 months
    • Talley NJ, Venables TL, Green JR, et al. Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months. Eur J Gastroenterol Hepatol 2002 14 : 857 863.
    • (2002) Eur J Gastroenterol Hepatol , vol.14 , pp. 857-863
    • Talley, N.J.1    Venables, T.L.2    Green, J.R.3
  • 15
    • 24944540256 scopus 로고    scopus 로고
    • On-demand therapy with pantoprazole 20 mg as effective long-term management of reflux disease in patients with mild GERD: The ORION trial
    • DOI 10.1159/000087661
    • Scholten T, Dekkers CP, Schutze K, Korner T, Bohuschke M, Gatz G. On-demand therapy with pantoprazole 20 mg as effective long-term management of reflux disease in patients with mild GERD: the ORION trial. Digestion. 2005 72 : 76 85. (Pubitemid 41507266)
    • (2005) Digestion , vol.72 , Issue.2-3 , pp. 76-85
    • Scholten, T.1    Dekkers, C.P.M.2    Schutze, K.3    Korner, T.4    Bohuschke, M.5    Gatz, G.6
  • 16
    • 23944433411 scopus 로고    scopus 로고
    • Pantoprazole 20 mg on demand is effective in the long-term management of patients with mild gastro-oesophageal reflux disease
    • DOI 10.1097/00042737-200509000-00009
    • Kaspari S, Kupcinskas L, Heinze H, Berghofer P. Pantoprazole 20 mg on demand is effective in the long-term management of patients with mild gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 2005 17 : 935 941. (Pubitemid 41192132)
    • (2005) European Journal of Gastroenterology and Hepatology , vol.17 , Issue.9 , pp. 935-941
    • Kaspari, S.1    Kupcinskas, L.2    Heinze, H.3    Berghofer, P.4
  • 17
    • 1542277920 scopus 로고    scopus 로고
    • Efficacy of lansoprazole on demand therapy in the treatment of non-erosive reflux disease and functional ulcer-like dyspepsia
    • Cooper A, Baxter G. Efficacy of lansoprazole on demand therapy in the treatment of non-erosive reflux disease and functional ulcer-like dyspepsia. Gut 2003 52 : A137.
    • (2003) Gut , vol.52 , pp. 137
    • Cooper, A.1    Baxter, G.2
  • 18
    • 3242890564 scopus 로고    scopus 로고
    • Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease
    • DOI 10.1111/j.1365-2036.2004.01999.x
    • Bytzer P, Blum A, De Herdt D, Dubois D. Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease. Aliment Pharmacol Ther 2004 20 : 181 188. (Pubitemid 38998216)
    • (2004) Alimentary Pharmacology and Therapeutics , vol.20 , Issue.2 , pp. 181-188
    • Bytzer, P.1    Blum, A.2    De Herdt, D.3    Dubois, D.4
  • 19
    • 3543002869 scopus 로고    scopus 로고
    • On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice: Effectiveness, health-related quality of life, and patient satisfaction
    • DOI 10.1023/B:DDAS.0000034551.39324.c3
    • Ponce J, Arguello L, Bastida G, Ponce M, Ortiz V, Garrigues V. On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice: effectiveness, health-related quality of life, and patient satisfaction. Dig Dis Sci 2004 49 : 931 936. (Pubitemid 39012275)
    • (2004) Digestive Diseases and Sciences , vol.49 , Issue.6 , pp. 931-936
    • Ponce, J.1    Arguello, L.2    Bastida, G.3    Ponce, M.4    Ortiz, V.5    Garrigues, V.6
  • 23
    • 27744532756 scopus 로고    scopus 로고
    • Economic analysis of on-demand maintenance therapy with proton pump inhibitors in patients with non-erosive reflux disease
    • DOI 10.2165/00019053-200523100-00006
    • Hughes DA, Bodger K, Bytzer P, De Herdt D, Dubois D. Economic analysis of on-demand maintenance therapy with proton pump inhibitors in patients with non-erosive reflux disease. Pharmacoeconomics. 2005 23 : 1031 1041. (Pubitemid 41603436)
    • (2005) PharmacoEconomics , vol.23 , Issue.10 , pp. 1031-1041
    • Hughes, D.A.1    Bodger, K.2    Bytzer, P.3    De Herdt, D.4    Dubois, D.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.